Skip to Main Content

Paper Details

Differential outcomes and immune checkpoint inhibitor response among endometrial cancer patients with MLH1 hypermethylation versus MLH1 "Lynch-like" mismatch repair gene mutation.
1
2023
CCND1, DNA damage repair genes, ER, Endometrial cancer, FGFR2, IFN, JAK1, MLH1, MLH1 hypermethylated tumors, MLH1 mutated tumors, PD-L1, PR, PTEN, Patients, T cell, TP53, endometrial cancer, endometrial tumors, immune cell infiltrates, immune checkpoint gene, interferon gamma, mismatch repair deficient endometrial tumors, patients, tumors

Datasets

Release 1.2